Renal cancer management is challenging from diagnosis to treatment and follow-up. In
cases of small renal masses and cystic lesions the differential diagnosis of benign or …

Magnetic resonance imaging (MRI) has gained increasing importance in the management of
rectal cancer over the last two decades. The role of MRI in patients with rectal cancer has …

According to the main international clinical guidelines, the recommended treatment for
locally-advanced rectal cancer is neoadjuvant chemoradiotherapy followed by surgery …

Objectives To systematically review published studies on the use of radiomics of the
pancreas. Methods The search was conducted in the MEDLINE database. Human studies …

Background To analyse the performance of multicentre pre-treatment MRI-based radiomics
(MBR) signatures combined with clinical baseline characteristics and neoadjuvant treatment …

The high incidence of rectal cancer in both sexes makes it one of the most common tumors,
with significant morbidity and mortality rates. To define the best treatment option and …

The assessment of nodal involvement in patients with rectal cancer (RC) is fundamental in
disease management. Magnetic Resonance Imaging (MRI) is routinely used for local and …

Background Twenty‐five percent of rectal adenocarcinoma patients achieve pathologic
complete response (pCR) to neoadjuvant chemoradiation and could avoid proctectomy …

Purpose MRI-based tumor response prediction to neoadjuvant systemic therapy (NST) in
breast cancer patients is increasingly being studied using radiomics with outcomes that …

Locally advanced rectal cancer (LARC) response to neoadjuvant chemoradiotherapy
(nCRT) is very heterogeneous and up to 30% of patients are considered non-responders …